Latham & Watkins advises Phathom Pharmaceuticals in pricing of US$130 million public offering of common stock.Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing…
Phathom Pharmaceuticals’ $130 Million Public Offering of Common Stock
